100
DAFTAR PUSTAKA ADA, 2012. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 35, S64–S71. doi:10.2337/dc12-s064 ADA, 2013. Economic Costs of Diabetes in the U.S. in 2012. Diabetes Care 36, 1033–1046. doi:10.2337/dc12-2625 ADA, 2014. Standards of Medical Care in Diabetes 2014. Diabetes Care 37, S14– S80. doi:10.2337/dc14-S014 AIHW, 2008. Diabetes Australian Facts 2008. Australian Institute of Health and Welfare, Australia. Andayani, T.M., 2013. Farmakoekonomi Prinsip dan Metodologi. Bursa Ilmu, Yogyakarta. Ballesta, M., Carral, F., Olveira, G., Girón, J.A., Aguilar, M., 2006. Economic cost associated with type II diabetes in Spanish patients. Eur. J. Health Econ. 7, 270–275. doi:10.1007/s10198-006-0367-9 Brunton, L., Chabner, B., Knollman, B., 2011. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, Twelfth Edition. McGraw-Hill Education. Burrows, N.R., Li, Y., Geiss, L.S., 2010. Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the U.S. Continues to Decline. Diabetes Care 33, 73–77. doi:10.2337/dc09-0343 CDC, 2013. Adult Diabetes Prevalence in New York State. Centers for Disease Control and Prevention Department of Health. Clarke, P., Leal, J., Kelman, C., Smith, M., Colagiuri, S., 2008. Estimating the cost of complications of diabetes in Australia using administrative healthcare data. Value Health J. Int. Soc. Pharmacoeconomics Outcomes Res. 11, 199–206. doi:10.1111/j.1524-4733.2007.00228.x Costa, N., Derumeaux, H., Rapp, T., Garnault, V., Ferlicoq, L., Gillette, S., Andrieu, S., Vellas, B., Lamure, M., Grand, A., Molinier, L., 2012. Methodological considerations in cost of illness studies on Alzheimer disease. Health Econ. Rev. 2, 18. doi:10.1186/2191-1991-2-18
101
Dahlan, M.S., 2013. Statistik untuk Kedokteran dan Kesehatan, 5th ed. Penerbit Salemba, Jakarta. Dinkes DIY, 2013. Profil Kesehatan Daerah Istimewa Yogyakarta 2013. Dinas Kesehatan Daerah Istimewa Yogyakarta, Yogyakarta. DiPiro, J., 2013. Pharmacotherapy Principles and Practice, Third Edition. McGraw Hill Professional. Donnan, P.T., Leese, G.P., Morris, A.D., 2000. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care 23, 1774–1779. doi:10.2337/diacare.23.12.1774 Elliott, R., Payne, K., 2005. Essentials of Economic Evaluation in Healthcare. Pharmaceutical Press. Ferrara, A., 2007. Increasing Prevalence of Gestational Diabetes Mellitus: A public health perspective. Diabetes Care 30, S141–S146. doi:10.2337/dc07-s206 Finkelstein, E.A., Chay, J., Bajpai, S., 2014. The Economic Burden of SelfReported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households. PLoS ONE 9, e99572. doi:10.1371/journal.pone.0099572 Fowler, M.J., 2008. Microvascular and Macrovascular Complications of Diabetes. Clin. Diabetes 26, 77–82. doi:10.2337/diaclin.26.2.77 Fraze, T., Jiang, H.J., Burgess, J., 2006. Hospital Stays for Patients with Diabetes, 2008: Statistical Brief #93, in: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Health Care Policy and Research (US), Rockville (MD). Govan, L., Wu, O., Briggs, A., Colhoun, H.M., McKnight, J.A., Morris, A.D., Pearson, D.W.M., Petrie, J.R., Sattar, N., Wild, S.H., Lindsay, R.S., Scottish Diabetes Research Network Epidemiology Group, 2011. Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 54, 2000–2008. doi:10.1007/s00125-011-2176-7
102
Grover, S., Avasthi, A., Bhansali, A., Chakrabarti, S., Kulhara, P., 2005. Cost of ambulatory care of diabetes mellitus: a study from north India. Postgrad. Med. J. 81, 391–395. doi:10.1136/pgmj.2004.024299 Hall, J.E., 2010. Guyton and Hall Textbook of Medical Physiology: Enhanced Ebook. Elsevier Health Sciences. Hammer, G.D., McPhee, S.J., 2014. Pathophysiology of Disease: An Introduction to Clinical Medicine 7/E: An Introduction to Clinical Medicine 7/E (EBOOK). McGraw Hill Professional. Harlina, 2011. Evaluasi Biaya Riil Pasien Rawat Inap Jamkesmas dengan Tarif INA -DRG’s dalam Rangka Penurunan Selisih Biaya Pelayanan Pelayanan di Rumah Sakit Umum Haji Surabaya (Studi Kasus Diagnosis Diabetes Mellitus). Tesis, Fakultas Ilmu Kesehatan, Universitas Airlangga, Surabaya. Hawley, J.A., Lessard, S.J., 2008. Exercise training-induced improvements in insulin action. Acta Physiol. Oxf. Engl. 192, 127–135. doi:10.1111/j.17481716.2007.01783.x Henriksson, F., Agardh, C.-D., Berne, C., Bolinder, J., Lönnqvist, F., Stenström, P., Östenson, C.-G., Jönsson, B., 2000. Direct medical costs for patients with type 2 diabetes in Sweden. J. Intern. Med. 248, 387–396. doi:10.1046/j.1365-2796.2000.00749.x Huang, E.S., Basu, A., O’Grady, M., Capretta, J.C., 2009. Projecting the Future Diabetes Population Size and Related Costs for the U.S. Diabetes Care 32, 2225–2229. doi:10.2337/dc09-0459 IDF, 2013. IDF Diabetes Atlas, 6th edition, 2013, Sixth edition. ed. International Diabetes Federation, Belgium. Jelantik, G., Haryati, E., 2014. Hubungan Faktor Resiko umur, Jenis Kelamin, Kegemukan dan Hipertensi dengan Kejadian Diabetes Mellitus Tipe II Di Wilayah Kerja Puskesmas Mataram. Dinas Kesehatan. Provinsi NTB, 1 8, 39–44. Kanavos, P., Aardweg, V.D.S., Schurer, W., 2012. Diabetes Expenditure, Burden of Disease and Management in 5 EU Countries. London School of Economics Health, London.
103
Katzung, B., Masters, S., Trevor, A., 2012. Basic and Clinical Pharmacology 12/E. McGraw Hill Professional. Kemenkes RI, 2006. Pharmaceutical Care Untuk Penyakit Diabetes, edisi 2. Kementerian Kesehatan Republik Indonesia, Jakarta. Kemenkes RI, 2012a. Pedoman Penerapan Kajian Kementerian Kesehatan Republik Indonesia, Jakarta.
Farmakoekonomi.
Kemenkes RI, 2012b. Peraturan Menteri Kesehatan Republik Indonesia Nomor 29 Tahun 2012 tentang Perubahan atas Peraturan Menteri Kesehatan Nomor 416/Menkes/PER/II2011 tentang Tarif Pelayanan Kesehatan bagi Peserta PT Askes (PERSERO). Kementerian Kesehatan Republik Indonesia, Jakarta. Kemenkes RI, 2013a. Riset Kesehatan Dasar: Riskesdas 2013. Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI, Jakarta. Kemenkes RI, 2013b. Peraturan Menteri Kesehatan Republik Indonesia Nomor 69 Tahun 2013 tentang Standar Tarif Pelayanan Kesehatan pada Fasilitas Kesehatan Tingkat Pertama dan Fasilitas Kesehatan Tingkat Lanjutan dalam Penyelenggaraan Program Jaminan Kesehatan. Kementerian Kesehatan Republik Indonesia, Jakarta. Kemenkes RI, 2013c. Buletin BUK Mei 2013. Kementerian Kesehatan Republik Indonesia, Jakarta. Kemenkes RI, 2013d. Peraturan Menteri Kesehatan Republik Indonesia Nomor 71 Tahun 2013 tentang Pelayanan Kesehatan pada Jaminan Kesehatan Nasional. Kementerian Kesehatan Republik Indonesia, Jakarta. Kemenkes RI, 2014. Peraturan Menteri Kesehatan Republik Indonesia Nomor 27 Tahun 2014 tentang Petunjuk Teknis Sistem Indonesian Case Base Groups (INA-CBG’s). Kementerian Kesehatan Republik Indonesia, Jakarta. Kernick, D., 2002. Getting Health Economics Into Practice. Radcliffe Publishing. Koda-Kimble, M.A., 2009. Applied Therapeutics: The Clinical Use of Drugs. Wolters Kluwer Health/Lippincott Williams & Wilkins. Leigh, P., Markowitz, S., Fahs, M., Landrigan, P., 2003. Costs of Occupational Injuries and Illnesses. University of Michigan Press.
104
Mateti, U., Kunduru, B., Akari, S., 2013. Health-care cost of diabetes in South India: A cost of illness study. J. Res. Pharm. Pract. 2, 114. doi:10.4103/2279-042X.122382 McCarthy, R.L., Schafermeyer, K.W., 2010. Introduction to Healthcare Delivery: A Primer for Pharmacists, Text and Study Guide, Online Access Code. Jones & Bartlett Learning. Morrish, N.J., Wang, S.L., Stevens, L.K., Fuller, J.H., Keen, H., 2001. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 Suppl 2, S14–21. Oliva, J., Lobo, F., Molina, B., Monereo, S., 2004. Direct Health Care Costs of Diabetic Patients in Spain. Diabetes Care 27, 2616–2621. doi:10.2337/diacare.27.11.2616 Posey, L.M., 2011. Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition. McGraw-Hill Education. Rascati, K., 2013. Essentials of Pharmacoeconomics. Lippincott Williams & Wilkins. Report of World Economic Forum, 2011. The Global Economic Burden of Noncommunicable Diseases. Geneva. Sari, R.P., Pramantara, P.D., 2013. Perbandingan Biaya Riil dengan Tarif Paket INA-CBG’s dan Analisis Faktor yang Mempengaruhi Biaya Riil Pada Pasien Diabetes Mellitus Rawat Inap Jamkesmas di RSUP Dr. Sardjito Yogyakarta. Tesis, Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta. Silbernagl, S., Lang, F., 2011. Color Atlas of Pathophysiology. Thieme. Soegondo, S., Soewondo, P., Subekti, I., 2011. Penatalaksanaan Diabetes Mellitus Terpadu, edisi 2. Fakultas Kedokteran Universitas Indonesia, Jakarta. Soewondo, P., Ferrario, A., Tahapary, D.L., 2013. Challenges in diabetes management in Indonesia. Glob. Health 9, 63. doi:10.1186/1744-8603-963 Speckman, R.A., Frankenfield, D.L., Roman, S.H., Eggers, P.W., Bedinger, M.R., Rocco, M.V., McClellan, W.M., 2004. Diabetes is the strongest risk factor
105
for lower-extremity amputation in new hemodialysis patients. Diabetes Care 27, 2198–2203. Sulaiman, W., 2004. Analisis Regresi Menggunakan SPSS Contoh Kasus dan Pemecahannya. ANDI, Yogyakarta. Tapp, R.J., Shaw, J.E., de Courten, M.P., Dunstan, D.W., Welborn, T.A., Zimmet, P.Z., AusDiab Study Group, 2003. Foot complications in Type 2 diabetes: an Australian population-based study. Diabet. Med. J. Br. Diabet. Assoc. 20, 105–113. Tarricone, R., 2006. Cost-of-illness analysis. Health Policy 77, 51–63. doi:10.1016/j.healthpol.2005.07.016 Umpierrez, G.E., Murphy, M.B., Kitabchi, A.E., 2002. Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome. Diabetes Spectr. 15, 28–36. doi:10.2337/diaspect.15.1.28 Wertheimer, A.I., Rychlik, R., 2002. Strategies in Pharmacoeconomics and Outcomes Research. CRC Press. WHO, 2000. Obesity: Preventing and Managing the Global Epidemic. World Health Organization. Wild, S., Roglic, G., Green, A., Sicree, R., King, H., 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053. Zhuo, X., Zhang, P., Hoerger, T.J., 2013. Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications. Am. J. Prev. Med. 45, 253–261. doi:10.1016/j.amepre.2013.04.017
